A growing number of lawsuits allege that the manufacturers of certain

GLP-1 drugs like Ozympic, Wagovi, and Manjaro, failed to sufficiently warn of the risks

of certain severe injuries.

As more adverse experiences come to light, how are drug makers responding to safety

concerns? Hello, and welcome to USA Today's The Excerpt. I'm Dana Taylor. Today is Wednesday,

January 28, 26. Since 2023, roughly 4,200 patients have filed lawsuits challenging the safety of GLP-1s.

Joining me to discuss some of those cases and the response from drug manufacturers

is USA Today investigative data reporter Austin Bast.

It's good to have you back on the excerpt, Austin.

Yeah, thanks for having me back. As you reported, the most common medical complaint by far is something known as

stomach paralysis. What is that exactly, Austin? How does it affect the body? It's what it sounds like,

really. I mean, it's when your stomach stops moving. The muscles are weakened,

and so it stops moving your food into the intestine so it can be digested. So what that happens is it

causes people to feel full very quickly, even with just a couple bites of food sometimes,

and then it can lead to nausea, vomiting, bloating, pain, and other

sorts of problems. And there's not a cure that's known, but it can often be managed through

dietary changes and lifestyle changes. Another major complaint is intestinal obstructions. How severe

are some of the worst cases? What

have patients alleged here?

Yeah. So aside from the stomach paralysis, I mean, there's some really just gruesome

symptoms that the plaintiffs and all these lawsuits are describing. Many of them result in visits

to the emergency room or multiple day hospitalizations and sometimes several hospitalizations

...